Literature DB >> 11117578

Combination analysis of genetic alterations and cell proliferation in small intestinal carcinomas.

T Muneyuki1, M Watanabe, M Yamanaka, S Isaji, Y Kawarada, R Yatani.   

Abstract

We analyzed K-ras and p53 mutations, microsatellite instability (MSI), and loss of heterozygosity (LOH) using the polymerase chain reaction (PCR) methods, as well as p53 expression and the Ki-67 labeling index (LI) using immunohistochemistry in 10 duodenal and 10 jejunal/ileal carcinomas. K-ras mutations were detected in two duodenal (20%) and three jejunal/ileal (30%) carcinomas and p53 mutations in one (10%) and three (30%), respectively. LOH of 17p was detected in two duodenal (20%) and two jejunal/ileal (20%) carcinomas and p53 expression in four duodenal (40%) and four jejunal/ileal (40%). One duodenal (10%) and two jejunal/ileal (20%) carcinomas demonstrated MSI. LOH of APC was detected in three jejunal/ileal (30%), but none of the duodenal carcinomas. The Ki-67 LI was 44% in duodenal and 52.6% in jejunal/ileal carcinomas. A subset of small intestinal carcinomas showed involvement of K-ras and p53 mutations, LOH of APC, and MSI. A difference was also apparent for LOH of APC between duodenal and jejunal/ileal carcinomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11117578     DOI: 10.1023/a:1005560428937

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

1.  Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine.

Authors:  A Rashid; S R Hamilton
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

2.  Dinucleotide repeat polymorphism at the D18S34 locus.

Authors:  J L Weber; P E May
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

Review 3.  Molecular genetics of colon cancer.

Authors:  I Tomlinson; M Ilyas; M Novelli
Journal:  Cancer Metastasis Rev       Date:  1997-06       Impact factor: 9.264

4.  The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors.

Authors:  N Younes; N Fulton; R Tanaka; J Wayne; F H Straus; E L Kaplan
Journal:  Cancer       Date:  1997-05-01       Impact factor: 6.860

5.  Mutations of ras genes are relatively frequent in Japanese prostate cancers: pointing to genetic differences between populations.

Authors:  T Shiraishi; T Muneyuki; K Fukutome; H Ito; T Kotake; M Watanabe; R Yatani
Journal:  Anticancer Res       Date:  1998 Jul-Aug       Impact factor: 2.480

6.  A CA repeat 30-70 KB downstream from the adenomatous polyposis coli (APC) gene.

Authors:  L Spirio; G Joslyn; L Nelson; M Leppert; R White
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

7.  The association between cancers of the small and large bowel.

Authors:  A I Neugut; J Santos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1993 Nov-Dec       Impact factor: 4.254

8.  Frequent K-ras mutations in small bowel adenocarcinomas.

Authors:  T Sutter; N Arber; S F Moss; R I Findling; A I Neugut; I B Weinstein; P R Holt
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

9.  p53 gene mutations in human prostate cancers in Japan: different mutation spectra between Japan and western countries.

Authors:  M Watanabe; T Ushijima; H Kakiuchi; T Shiraishi; R Yatani; J Shimazaki; T Kotake; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1994-09

10.  Frequent genetic instability in small intestinal carcinomas.

Authors:  K Hibi; K Kondo; S Akiyama; K Ito; H Takagi
Journal:  Jpn J Cancer Res       Date:  1995-04
View more
  8 in total

Review 1.  The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.

Authors:  Simon Schimmack; Bernhard Svejda; Benjamin Lawrence; Mark Kidd; Irvin M Modlin
Journal:  Langenbecks Arch Surg       Date:  2011-01-28       Impact factor: 3.445

2.  Clinicopathologic and prognostic associations of KRAS and BRAF mutations in small intestinal adenocarcinoma.

Authors:  Sun-Young Jun; Misung Kim; Mi Jin Gu; Young Kyung Bae; Hee-Kyung Chang; Eun Sun Jung; Kee-Taek Jang; Jihun Kim; Eunsil Yu; Dae Woon Eom; Seung-Mo Hong
Journal:  Mod Pathol       Date:  2016-02-19       Impact factor: 7.842

3.  Microsatellite instability in the high-grade dysplasia component of duodenal adenoma is associated with progression to adenocarcinoma.

Authors:  Nobuyoshi Aso; Kouki Ohtsuka; Junji Shibahara; Hirotomo Koda; Teppei Morikawa; Nobutsugu Abe; Takashi Watanabe; Hiroaki Ohnishi
Journal:  Surg Today       Date:  2022-07-24       Impact factor: 2.540

4.  KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma.

Authors:  Tao Fu; Angela A Guzzetta; Jana Jeschke; Rajita Vatapalli; Pujan Dave; Craig M Hooker; Richard Morgan; Christine A Iacobuzio-Donahue; Baohua Liu; Nita Ahuja
Journal:  Int J Cancer       Date:  2013-01-18       Impact factor: 7.396

5.  Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension.

Authors:  Waleed Ajaj; Susanne C Goehde; Hubert Schneemann; Stefan G Ruehm; Jörg F Debatin; Thomas C Lauenstein
Journal:  Eur Radiol       Date:  2003-11-22       Impact factor: 5.315

Review 6.  Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology.

Authors:  Mark Kidd; Irvin M Modlin; Lisa Bodei; Ignat Drozdov
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-01-12

7.  Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing.

Authors:  Atsushi Tatsuguchi; Takeshi Yamada; Koji Ueda; Hiroyasu Furuki; Aitoshi Hoshimoto; Takayoshi Nishimoto; Jun Omori; Naohiko Akimoto; Katya Gudis; Shu Tanaka; Shunji Fujimori; Akira Shimizu; Katsuhiko Iwakiri
Journal:  BMC Cancer       Date:  2022-07-02       Impact factor: 4.638

8.  Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study.

Authors:  T Aparicio; M Svrcek; A Zaanan; E Beohou; A Laforest; P Afchain; Emmanuel Mitry; J Taieb; F Di Fiore; J-M Gornet; A Thirot-Bidault; I Sobhani; D Malka; T Lecomte; C Locher; F Bonnetain; P Laurent-Puig
Journal:  Br J Cancer       Date:  2013-11-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.